Prx Life 2024

1 papers

Top Research Directions

The 4 research directions with Prx Life 2024 papers, ranked by paper count, next to 2023. Share is the fraction of the edition’s papers in the direction.

#Direction20242023Share 2024Share 20232023 rank
1Attenuating Pathogen Virulence to Mitigate Selection Pressure10100.0%0.0%—
2Evolutionary Fitness Costs of Biological Resistance10100.0%0.0%—
3Overcoming Cell Line Specificity in Computational Oncology10100.0%0.0%—
4The Impact of Simplification in Computational Biological Models10100.0%0.0%—

Download all directions as CSV

Institutions

Institutions credited by Prx Life 2024 papers: a paper credits every institution named in its affiliations, once. 4 institutions share 1 credited papers.

#InstitutionPapersShare20232023 rank
100fpjq451 1100.0%0—
2Case Western Reserve University 1100.0%0—
3Cleveland Clinic 1100.0%0—
4Oslo University Hospital 1100.0%0—

Download all institutions as CSV

About this data

Papers. Prx Life 2024 lists 1 papers on Lacuna, duplicate versions counted once; rejected and withdrawn submissions are left out.

Directions. Directions are Lacuna’s clustering of the concept elements extracted from each paper, so a paper can belong to several and direction counts add up to more than the paper count. A direction’s share is its papers divided by the edition’s papers. Comparisons with 2023 use shares, since the edition went from 1 to 1 papers.

Institutions. A paper credits each institution named in its affiliations, resolved to a ROR record, once. 1 of 1 papers (100.0%) credit at least one institution and are the base for institution shares; the rest have no resolved affiliation yet.

Data. Counts come from Lacuna’s data build of 2026-11-19 and change as papers are added. Tables as CSV: directions · institutions. Cite as: Lacuna, “Prx Life 2024”, https://lacuna.tiptreesystems.com/venue/prx-life/2024.

Top Authors

AuthorPapers
Michael Hinczewski1

Papers

Title
Frequency-Dependent Ecological Interactions Increase the Prevalence, and Shape the Distribution, of Preexisting Drug Resistance